Jefferies Financial Group Cuts Clorox (NYSE:CLX) Price Target to $145.00

Clorox (NYSE:CLXFree Report) had its target price decreased by Jefferies Financial Group from $167.00 to $145.00 in a research report sent to investors on Thursday,Benzinga reports. Jefferies Financial Group currently has a buy rating on the stock.

Several other brokerages have also weighed in on CLX. UBS Group cut their price objective on shares of Clorox from $176.00 to $154.00 and set a “neutral” rating on the stock in a report on Thursday, April 17th. Morgan Stanley cut their price target on shares of Clorox from $165.00 to $150.00 and set an “equal weight” rating on the stock in a research note on Tuesday, May 6th. Wells Fargo & Company decreased their price target on shares of Clorox from $145.00 to $142.00 and set an “equal weight” rating on the stock in a report on Tuesday, May 6th. Barclays dropped their price objective on Clorox from $134.00 to $129.00 and set an “underweight” rating for the company in a report on Wednesday, May 7th. Finally, Citigroup cut their target price on Clorox from $165.00 to $150.00 and set a “neutral” rating on the stock in a research report on Monday, April 14th. Three research analysts have rated the stock with a sell rating, ten have given a hold rating and one has issued a buy rating to the company’s stock. Based on data from MarketBeat.com, Clorox has an average rating of “Hold” and an average target price of $149.50.

Read Our Latest Stock Report on Clorox

Clorox Trading Down 1.2%

Shares of CLX opened at $118.03 on Thursday. Clorox has a fifty-two week low of $117.35 and a fifty-two week high of $171.37. The company has a market capitalization of $14.55 billion, a PE ratio of 21.19, a price-to-earnings-growth ratio of 2.70 and a beta of 0.54. The stock has a fifty day moving average of $131.62 and a two-hundred day moving average of $145.61. The company has a debt-to-equity ratio of 13.07, a quick ratio of 0.44 and a current ratio of 0.74.

Clorox (NYSE:CLXGet Free Report) last released its earnings results on Monday, May 5th. The company reported $1.45 EPS for the quarter, missing the consensus estimate of $1.57 by ($0.12). Clorox had a net margin of 9.89% and a return on equity of 324.23%. The business had revenue of $1.67 billion during the quarter, compared to analyst estimates of $1.74 billion. During the same quarter in the previous year, the company posted $1.71 earnings per share. The business’s revenue for the quarter was down 8.0% compared to the same quarter last year. As a group, analysts forecast that Clorox will post 7.15 EPS for the current year.

Insider Activity at Clorox

In other news, Director Pierre R. Breber bought 4,000 shares of Clorox stock in a transaction dated Wednesday, May 7th. The shares were acquired at an average cost of $136.57 per share, with a total value of $546,280.00. Following the completion of the transaction, the director now owns 4,000 shares in the company, valued at approximately $546,280. This trade represents a ∞ increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. 0.57% of the stock is owned by insiders.

Institutional Investors Weigh In On Clorox

A number of large investors have recently added to or reduced their stakes in CLX. Redwood Park Advisors LLC purchased a new position in Clorox in the 4th quarter valued at about $26,000. Millstone Evans Group LLC purchased a new position in Clorox in the fourth quarter valued at about $31,000. Wood Tarver Financial Group LLC acquired a new stake in Clorox during the 4th quarter valued at approximately $31,000. GKV Capital Management Co. Inc. purchased a new stake in Clorox during the 4th quarter worth approximately $32,000. Finally, Aster Capital Management DIFC Ltd acquired a new position in shares of Clorox in the 4th quarter valued at approximately $33,000. 78.53% of the stock is owned by institutional investors and hedge funds.

Clorox Company Profile

(Get Free Report)

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

See Also

Analyst Recommendations for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.